CXCL12 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: This is the first report that reveals the important role of the CXCL12-CXCR4 signaling axis in enhancing resistance to GEM and the effect of CXCR4 antagonists on GEM-resistant PaCa cells.